Symbols / ITGR Stock $85.16 -0.54% Integer Holdings Corporation

Healthcare • Medical Devices • United States • NYQ
ITGR (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
About

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Fundamentals
Scroll to Statements
Market Cap 2.93B Enterprise Value 4.23B Income 102.83M Sales 1.85B Book/sh 50.85 Cash/sh 0.50
Dividend Yield Payout 0.00% Employees 11000 IPO P/E 29.47 Forward P/E 11.79
PEG 1.46 P/S 1.58 P/B 1.67 P/C EV/EBITDA 11.22 EV/Sales 2.28
Quick Ratio 2.05 Current Ratio 3.32 Debt/Eq 75.44 LT Debt/Eq EPS (ttm) 2.89 EPS next Y 7.23
EPS Growth 52.90% Revenue Growth 5.00% Earnings 2026-04-30 ROA 4.75% ROE 6.11% ROIC
Gross Margin 27.39% Oper. Margin 12.79% Profit Margin 5.55% Shs Outstand 34.07M Shs Float 33.99M Short Float 12.99%
Short Ratio 4.64 Short Interest 52W High 127.56 52W Low 62.00 Beta 0.71 Avg Volume 776.18K
Volume 190.34K Target Price $93.25 Recom Buy Prev Close $85.62 Price $85.16 Change -0.54%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$93.25
Mean price target
2. Current target
$85.16
Latest analyst target
3. DCF / Fair value
$40.62
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$85.16
Low
$84.00
High
$101.00
Mean
$93.25

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-20 main Citigroup Neutral → Neutral $92
2026-02-20 main Wells Fargo Equal-Weight → Equal-Weight $84
2026-02-20 up Benchmark Hold → Buy $95
2026-02-20 main Truist Securities Buy → Buy $97
2025-12-18 main Truist Securities Buy → Buy $95
2025-12-11 main Citigroup Neutral → Neutral $75
2025-11-24 main Truist Securities Buy → Buy $86
2025-11-03 main Citigroup Neutral → Neutral $69
2025-10-24 main Truist Securities Buy → Buy $88
2025-10-24 reit Raymond James Outperform → Outperform $95
2025-10-24 main Piper Sandler Overweight → Overweight $82
2025-10-24 down Benchmark Buy → Hold
2025-10-24 main Keybanc Overweight → Overweight $93
2025-10-24 down Wells Fargo Overweight → Equal-Weight $80
2025-10-24 down Citigroup Buy → Neutral $77
2025-10-21 main Keybanc Overweight → Overweight $133
2025-10-15 main Truist Securities Buy → Buy $121
2025-07-25 main Raymond James Outperform → Outperform $143
2025-07-25 main Truist Securities Buy → Buy $137
2025-07-25 main Wells Fargo Overweight → Overweight $132
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-31 HARRIS JOHN A Officer 3,837
2026-03-24 BLACKWOOD LINDSAY K. General Counsel 3,483
2026-03-24 CARR TERENCE Officer 1,350
2026-03-13 THOMAS TOMMY P. Officer 825 $85.00 $70,125
2026-03-12 KAPITO AARON J. Director 410 $0.00 $0
2026-03-12 FLANAGAN JAMES FRANCIS Director 410 $0.00 $0
2026-02-24 KHALES PAYMAN Chief Executive Officer 43,060
2026-02-20 THOR KIRK K Officer 9,025 $0.00 $0
2026-02-20 THOMAS TOMMY P. Officer 1,862 $0.00 $0
2026-02-20 KHALES PAYMAN Chief Executive Officer 14,905 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1,853.64
+7.98%
1,716.60
+10.35%
1,555.66
+16.85%
1,331.28
Operating Revenue
1,853.64
+7.98%
1,716.60
+10.35%
1,555.66
+16.85%
1,331.28
Cost Of Revenue
1,353.25
+7.61%
1,257.58
+9.76%
1,145.77
+16.26%
985.52
Reconciled Cost Of Revenue
1,353.25
+7.61%
1,257.58
+9.76%
1,145.77
+16.26%
985.52
Gross Profit
500.39
+9.01%
459.01
+11.98%
409.89
+18.55%
345.76
Operating Expense
261.25
+9.48%
238.63
+1.48%
235.14
+7.95%
217.81
Research And Development
49.50
-7.35%
53.42
-13.78%
61.97
+3.69%
59.76
Selling General And Administration
211.75
+14.33%
185.20
+6.95%
173.17
+9.57%
158.05
Other Operating Expenses
2.11
+77.61%
1.19
Total Expenses
1,614.50
+7.91%
1,496.21
+8.35%
1,380.90
+14.76%
1,203.33
Operating Income
239.14
+8.51%
220.39
+26.11%
174.75
+36.58%
127.95
Total Operating Income As Reported
221.26
+6.26%
208.24
+27.50%
163.32
+44.95%
112.68
EBITDA
292.39
-5.96%
310.91
+21.69%
255.50
+29.08%
197.93
Normalized EBITDA
311.15
-3.69%
323.06
+21.03%
266.93
+25.20%
213.20
Reconciled Depreciation
130.67
+17.69%
111.03
+12.33%
98.84
+7.45%
91.99
EBIT
161.72
-19.09%
199.88
+27.59%
156.66
+47.87%
105.94
Total Unusual Items
-18.77
-54.48%
-12.15
-6.31%
-11.43
+25.17%
-15.27
Total Unusual Items Excluding Goodwill
-18.77
-54.48%
-12.15
-6.31%
-11.43
+25.17%
-15.27
Special Income Charges
-18.77
-54.48%
-12.15
-6.31%
-11.43
+25.17%
-15.27
Other Special Charges
0.89
Restructuring And Mergern Acquisition
17.88
+47.13%
12.15
+6.31%
11.43
-25.17%
15.27
Net Income
102.81
-14.25%
119.90
+32.26%
90.65
+36.57%
66.38
Pretax Income
125.40
-15.02%
147.56
+40.03%
105.38
+53.45%
68.68
Net Non Operating Interest Income Expense
-42.31
+24.94%
-56.37
-9.94%
-51.27
-37.60%
-37.27
Interest Expense Non Operating
36.32
-30.57%
52.32
+2.03%
51.27
+37.60%
37.27
Net Interest Income
-42.31
+24.94%
-56.37
-9.94%
-51.27
-37.60%
-37.27
Interest Expense
36.32
-30.57%
52.32
+2.03%
51.27
+37.60%
37.27
Other Income Expense
-71.43
-334.22%
-16.45
+9.09%
-18.09
+17.78%
-22.01
Other Non Operating Income Expenses
-53.21
-1411.28%
-3.52
-261.13%
-0.97
-208.45%
0.90
Gain On Sale Of Security
1.26
+237.47%
-0.92
Tax Provision
22.57
-14.88%
26.51
+63.25%
16.24
+81.87%
8.93
Tax Rate For Calcs
0.00
+0.00%
0.00
+16.88%
0.00
+18.46%
0.00
Tax Effect Of Unusual Items
-3.38
-54.48%
-2.19
-24.26%
-1.76
+11.35%
-1.99
Net Income Including Noncontrolling Interests
102.81
-14.25%
119.90
+32.26%
90.65
+36.57%
66.38
Net Income From Continuing Operation Net Minority Interest
102.83
-15.05%
121.05
+35.80%
89.14
+49.20%
59.75
Net Income From Continuing And Discontinued Operation
102.81
-14.25%
119.90
+32.26%
90.65
+36.57%
66.38
Net Income Continuous Operations
102.83
-15.05%
121.05
+35.80%
89.14
+49.20%
59.75
Net Income Discontinuous Operations
-0.02
+98.10%
-1.16
-176.78%
1.51
-77.27%
6.63
Normalized Income
118.22
-9.77%
131.02
+32.59%
98.81
+35.30%
73.03
Net Income Common Stockholders
102.81
-14.25%
119.90
+32.26%
90.65
+36.57%
66.38
Diluted EPS
2.89
-13.99%
3.36
+24.91%
2.69
+35.18%
1.99
Basic EPS
2.96
-17.09%
3.57
+31.25%
2.72
+36.00%
2.00
Basic Average Shares
34.73
+3.37%
33.60
+0.84%
33.32
+0.58%
33.13
Diluted Average Shares
35.59
-0.15%
35.65
+5.60%
33.76
+1.20%
33.36
Diluted NI Availto Com Stockholders
102.81
-14.25%
119.90
+32.26%
90.65
+36.57%
66.38
Earnings From Equity Interest
0.55
+170.51%
-0.78
+86.29%
-5.69
+25.47%
-7.64
Total Other Finance Cost
5.99
+47.62%
4.06
+14.73%
3.54
+83.98%
1.92
Line Item Trend 2025-12-31 2024-12-31
Total Assets
3,410.58
+10.81%
3,077.97
Current Assets
770.10
+14.75%
671.12
Cash Cash Equivalents And Short Term Investments
17.16
-63.13%
46.54
Cash And Cash Equivalents
17.16
-63.13%
46.54
Receivables
458.62
+31.40%
349.04
Accounts Receivable
346.08
+41.10%
245.27
Gross Accounts Receivable
346.68
+41.17%
245.57
Allowance For Doubtful Accounts Receivable
-0.60
-100.00%
-0.30
Other Receivables
112.55
+8.46%
103.77
Taxes Receivable
Inventory
253.74
+2.68%
247.13
Raw Materials
94.13
-10.03%
104.62
Work In Process
143.47
+13.14%
126.81
Finished Goods
16.14
+2.84%
15.70
Prepaid Assets
Assets Held For Sale Current
0.00
Other Current Assets
40.57
+42.81%
28.41
Total Non Current Assets
2,640.48
+9.71%
2,406.85
Net PPE
671.97
+15.94%
579.57
Gross PPE
1,241.01
+14.72%
1,081.75
Accumulated Depreciation
-569.04
-13.31%
-502.18
Properties
0.00
0.00
Land And Improvements
12.50
+5.84%
11.81
Buildings And Improvements
183.50
+14.71%
159.97
Machinery Furniture Equipment
685.70
+13.01%
606.76
Construction In Progress
106.47
+25.41%
84.89
Other Properties
137.17
+18.95%
115.32
Leases
115.67
+12.31%
102.99
Goodwill And Other Intangible Assets
1,936.34
+7.81%
1,796.02
Goodwill
1,110.91
+9.16%
1,017.73
Other Intangible Assets
825.43
+6.06%
778.29
Non Current Deferred Assets
8.99
+8.24%
8.31
Non Current Deferred Taxes Assets
8.99
+8.24%
8.31
Other Non Current Assets
23.17
+0.92%
22.96
Total Liabilities Net Minority Interest
1,663.93
+14.07%
1,458.76
Current Liabilities
232.04
+2.14%
227.17
Payables And Accrued Expenses
196.01
+7.81%
181.80
Payables
116.38
+11.39%
104.48
Accounts Payable
113.13
+11.46%
101.50
Current Accrued Expenses
79.63
+2.98%
77.33
Total Tax Payable
3.25
+9.07%
2.98
Income Tax Payable
3.25
+9.07%
2.98
Current Debt And Capital Lease Obligation
16.94
-22.69%
21.91
Current Debt
10.00
Other Current Borrowings
10.00
Current Capital Lease Obligation
16.94
+42.21%
11.91
Current Deferred Liabilities
5.21
+17.41%
4.44
Current Deferred Revenue
5.21
+17.41%
4.44
Other Current Liabilities
13.88
-27.03%
19.02
Total Non Current Liabilities Net Minority Interest
1,431.89
+16.26%
1,231.58
Liabilities Heldfor Sale Non Current
0.00
Long Term Debt And Capital Lease Obligation
1,295.66
+19.79%
1,081.62
Long Term Debt
1,185.18
+20.92%
980.15
Long Term Capital Lease Obligation
110.48
+8.89%
101.46
Non Current Deferred Liabilities
116.33
-6.65%
124.61
Non Current Deferred Taxes Liabilities
116.33
-6.65%
124.61
Other Non Current Liabilities
19.91
-21.49%
25.36
Stockholders Equity
1,746.64
+7.87%
1,619.21
Common Stock Equity
1,746.64
+7.87%
1,619.21
Capital Stock
0.04
+2.94%
0.03
Common Stock
0.04
+2.94%
0.03
Preferred Stock
0.00
0.00
Share Issued
35.48
+5.77%
33.55
Ordinary Shares Number
34.35
+2.39%
33.55
Treasury Shares Number
1.14
+18922483.33%
0.00
Additional Paid In Capital
771.22
+3.94%
741.98
Retained Earnings
994.05
+11.54%
891.25
Gains Losses Not Affecting Retained Earnings
58.20
+514.46%
-14.04
Treasury Stock
76.87
0.00
Other Equity Adjustments
58.20
+514.46%
-14.04
Total Equity Gross Minority Interest
1,746.64
+7.87%
1,619.21
Total Capitalization
2,931.82
+12.79%
2,599.37
Working Capital
538.06
+21.20%
443.95
Invested Capital
2,931.82
+12.36%
2,609.37
Total Debt
1,312.60
+18.95%
1,103.53
Net Debt
1,168.02
+23.78%
943.61
Capital Lease Obligations
127.42
+12.39%
113.38
Net Tangible Assets
-189.70
-7.30%
-176.80
Tangible Book Value
-189.70
-7.30%
-176.80
Interest Payable
6.44
+53.34%
4.20
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
196.15
-4.41%
205.21
+13.87%
180.21
+54.85%
116.38
Cash Flow From Continuing Operating Activities
196.15
-4.41%
205.21
+13.87%
180.21
+54.85%
116.38
Net Income From Continuing Operations
102.81
-14.25%
119.90
+32.26%
90.65
+36.57%
66.38
Depreciation Amortization Depletion
130.67
+17.69%
111.03
+12.33%
98.84
+7.45%
91.99
Depreciation And Amortization
130.67
+17.69%
111.03
+12.33%
98.84
+7.45%
91.99
Other Non Cash Items
63.10
+261.32%
17.46
-25.79%
23.54
+3.68%
22.70
Stock Based Compensation
23.22
-6.23%
24.77
+6.37%
23.28
+10.75%
21.02
Deferred Tax
-2.69
+80.96%
-14.11
-48.68%
-9.49
+45.77%
-17.50
Deferred Income Tax
-2.69
+80.96%
-14.11
-48.68%
-9.49
+45.77%
-17.50
Operating Gains Losses
-0.55
-170.51%
0.78
-86.29%
5.69
-25.47%
7.64
Change In Working Capital
-120.42
-120.45%
-54.62
-4.45%
-52.30
+31.05%
-75.85
Change In Receivables
-89.66
-258.94%
-24.98
-18.48%
-21.08
+56.91%
-48.92
Changes In Account Receivables
-82.38
-1161.21%
-6.53
+12.17%
-7.44
+82.03%
-41.38
Change In Inventory
-2.58
+85.75%
-18.08
+40.09%
-30.18
+46.80%
-56.72
Change In Prepaid Assets
-2.50
-989.52%
-0.23
+75.38%
-0.93
-221.73%
0.76
Change In Payables And Accrued Expense
-25.69
-126.59%
-11.34
-10595.28%
-0.11
-100.37%
29.03
Change In Accrued Expense
-20.27
-553.24%
4.47
-43.45%
7.91
+182.99%
-9.53
Change In Payable
-5.42
+65.72%
-15.81
-97.27%
-8.01
-120.78%
38.56
Change In Account Payable
-0.57
+96.59%
-16.62
-3096.15%
-0.52
-102.00%
26.04
Investing Cash Flow
-270.73
-38.54%
-195.41
-19.62%
-163.37
+18.49%
-200.42
Cash Flow From Continuing Investing Activities
-269.78
-10.52%
-244.11
-49.43%
-163.37
+18.49%
-200.42
Cash From Discontinued Investing Activities
-0.95
-101.95%
48.70
0.00
0.00
Net PPE Purchase And Sale
-91.03
+13.60%
-105.36
+12.16%
-119.94
-61.88%
-74.09
Purchase Of PPE
-91.03
+13.60%
-105.36
+12.16%
-119.94
-60.50%
-74.73
Sale Of PPE
0.04
-77.46%
0.17
-72.93%
0.64
Capital Expenditure
-91.03
+13.60%
-105.36
+12.16%
-119.94
-60.50%
-74.73
Net Investment Purchase And Sale
0.00
0.00
-100.00%
0.30
Sale Of Investment
0.00
0.00
-100.00%
0.30
Net Business Purchase And Sale
-178.87
-29.11%
-138.54
-217.75%
-43.60
+65.57%
-126.64
Purchase Of Business
-178.87
-29.11%
-138.54
-217.75%
-43.60
+65.57%
-126.64
Net Intangibles Purchase And Sale
-0.25
0.00
0.00
Purchase Of Intangibles
-0.25
0.00
0.00
Net Other Investing Changes
0.12
+158.29%
-0.21
-221.97%
0.17
Financing Cash Flow
43.56
+226.99%
13.32
+173.95%
-18.01
-119.48%
92.48
Cash Flow From Continuing Financing Activities
43.56
+226.99%
13.32
+173.95%
-18.01
-119.48%
92.48
Net Issuance Payments Of Debt
177.87
+993.15%
16.27
-40.69%
27.43
-71.10%
94.91
Issuance Of Debt
1,284.50
+367.94%
274.50
-68.42%
869.35
+423.71%
166.00
Repayment Of Debt
-1,106.63
-328.55%
-258.23
+69.33%
-841.92
-1084.27%
-71.09
Long Term Debt Issuance
1,284.50
+367.94%
274.50
-68.42%
869.35
+423.71%
166.00
Long Term Debt Payments
-1,106.63
-328.55%
-258.23
+69.33%
-841.92
-1084.27%
-71.09
Net Long Term Debt Issuance
177.87
+993.15%
16.27
-40.69%
27.43
-71.10%
94.91
Short Term Debt Issuance
Short Term Debt Payments
Net Short Term Debt Issuance
Net Common Stock Issuance
-50.01
0.00
0.00
Common Stock Payments
-50.01
0.00
0.00
Repurchase Of Capital Stock
-50.01
0.00
0.00
Proceeds From Stock Option Exercised
3.64
+391.11%
0.74
-67.78%
2.30
+1435.33%
0.15
Net Other Financing Charges
-87.94
-2281.85%
-3.69
+92.27%
-47.75
-1749.30%
-2.58
Changes In Cash
-31.02
-234.24%
23.11
+2078.77%
-1.17
-113.85%
8.44
Effect Of Exchange Rate Changes
1.64
+776.13%
-0.24
-142.63%
0.57
+127.82%
-2.05
Beginning Cash Position
46.54
+96.60%
23.67
-2.46%
24.27
+35.71%
17.89
End Cash Position
17.16
-63.13%
46.54
+96.60%
23.67
-2.46%
24.27
Free Cash Flow
105.12
+5.28%
99.85
+65.65%
60.27
+44.71%
41.65
Interest Paid Supplemental Data
32.41
-40.17%
54.17
+43.68%
37.70
+5.30%
35.80
Income Tax Paid Supplemental Data
28.22
-22.63%
36.47
+20.17%
30.35
+171.84%
11.16
Change In Income Tax Payable
-4.85
-698.40%
0.81
+110.82%
-7.49
-159.84%
12.52
Change In Tax Payable
-4.85
-698.40%
0.81
+110.82%
-7.49
-159.84%
12.52
Earnings Losses From Equity Investments
-0.55
-170.51%
0.78
-86.29%
5.69
-25.47%
7.64
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category